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Background and Objectives The management of platelet concentrate (PC) stocks
is not simple given their short shelf life and variable demand. In general,
managers decide on PC production based on personal experience. The objective
of this study was to provide a tool to help decide how many PC units to produce
each day in a more rational and objective way.
Materials and Methods From the historical data on PCs produced, transfused and
discarded in the Basque Country in 2012, a mathematical model was built, based
on the normality of the time series of the transfusions performed on each day of
the week throughout the year. This model was implemented in an easy-to-use
Excel spreadsheet and validated using real production data from 2013.
Results Comparing with real 2013 data, in the best scenario, the number of PC
units that expired was 877% lower, PC production, 143% lower and the age of
the PCs transfused nearly 1-day younger in the simulation. If we want to ensure
a minimum stock at the end of each day, the outdating rate and average age of
the transfused PCs progressively increase.
Conclusion The practical application of the designed tool can facilitate decision-
making about how many PC units to produce each day, resulting in very signifi-
cant reductions in PC production and wastage and corresponding cost savings,
together with an almost 1 day decrease in the mean age of PCs transfused.
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Introduction
Optimization of the platelet concentrate (PC) production
process is important for achieving a better use of health-
care resources. The management of PC inventories is dif-
ficult given the short shelf life of this product and the
fact that patients requiring platelet transfusion cannot
wait. This means that there is generally excess produc-
tion, which in turn leads to high rates of wastage due to
outdating, and higher economic costs. Further, given that
PCs are obtained from voluntary non-remunerated
donations, wastage of this type of product is ethically
unacceptable. Although the ultimate goal of the producers
of blood products and the users (blood transfusion ser-
vices) are the same, their requirements are different in
terms of production and management of the inventory:
the former focus on logistic and organizational issues and
the latter on clinical factors. In this context, we need to
search for a balance between production and demand that
is satisfactory from both perspectives.
Platelet component preparation processes vary not only
between but also within countries. In particular, there are
differences in production methods (apheresis, buffy coat
or platelet-rich plasma), the use of pathogen inactivation
procedures and/or additive solutions, and the shelf life of
the product (5 or 7 days), as well as transfusion policies
themselves. Further, the level of co-ordination between
hospital transfusion services and producers of blood com-
ponents differs between regions. Given all this, rates of
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wastage vary widely. In Spain, these rates range from 0
to 387% in hospitals and in production units are around
349 and 162% for products with shelf lives of 5 or
7 days, respectively [1]. A study carried out in 10 Euro-
pean countries found a mean discard rate of 14% [2].
In contrast, an outdating rate of just 1% was found
when using an information technology (IT) tool for opti-
mizing production (the thrombocyte inventory manage-
ment optimizer), but such tools are rarely used to guide
inventory management [3]. In general, decisions are made
on the basis of the personal experience of the people in
charge of the production, and situations of uncertainty
tend to result in overproduction. Given this, having
reviewed the literature on the use of mathematical tools
for optimizing PC inventory management [4–8], the
Basque Centre for Human Tissue and Transfusions (CVTTH)
contacted mathematicians at the University of the Basque
Country to undertake a collaborative project. The aim of
this project was to develop an IT tool that would support
decision-making on how many PC units to produce each
day in the CVTTH on the basis of objective criteria.
The mathematical model developed, which is relatively
easy to understand, assumes a normal distribution of
demand on each day of the week throughout the year, as
observed in the 2012 time series of transfusions. The
result is an easy-to-use Excel spreadsheet that provides
an estimate of the daily production of PCs required across
the planning horizon. To validate the model, we com-
pared the production level recommended by the model
with the real production in 2013.
Materials and methods
Basque blood transfusion network
The Basque transfusion network is composed of a pro-
duction centre (CVTTH), 12 public hospitals and nine
private clinics, although PCs are only kept in stock in
five public hospitals. When hospitals or clinics that do
not hold stock need to perform a transfusion, CVTTH
provides them directly and immediately with the units
required. There is a corporate information system cover-
ing all the aforementioned organizations, except five of
the private clinics, and this documents the entire chain
from donation to transfusion. In this way, there is direct
centralized management of all donations and 94% of
transfusions in the Basque Country. The shelf life of the
PCs is set at 5 days, even though it is tested for bacte-
ria, and each unit contains a minimum of 3 9 1011 pla-
telets, resuspended in an additive solution. In 2013, The
CVTTH produces and provides 10 300 units of PC; 47%
of the PC units were produced by apheresis (Terumo
BCT, Denver, CO, USA) and 53% by pooling five interim
platelet units obtained with a platelet-rich plasma
method using the REVEOS automated blood processing
system (Terumo BCT).
Mathematical model and data used: statistical
analysis
The model designed for the management of PCs in the
Basque Country assumes a single stock held by the
CVTTH, without considering the stock held at hospitals.
The CVTTH provided an Excel spreadsheet with daily his-
torical data on PCs produced, including units in stock,
discarded and transfused from 9 January 2012 to 29
December 2013. These data for the 103 complete weeks
were split into two sets: data for the first 51 weeks, which
were used to build the mathematical model; and those for
the 52 weeks of 2013, which were used to validate the
model, by comparing these real data for 2013 with the
model’s predictions.
Regarding the days of PC production, we have not
included Saturdays (little production) or Sundays (no pro-
duction), to simplify the model. The PC units produced on
Monday, Tuesday, Wednesday and Thursday are placed in
stock the following morning, with an age of 1 day, while
PCs produced on Friday become part of the stock the fol-
lowing Monday morning, with an age of 3 days, reflect-
ing the real process. At the end of each day, once all
transfusions have been given, outdated PC units are dis-
carded. The stock is updated daily in the mornings, after
both discarding outdated PCs and including the most
recent production. We have applied the first-in, first-out
(FIFO) blood management policy for transfusions. The
modelling is based on units of PCs transfused without
distinguishing between ABO/Rh groups or the source of
the PCs (apheresis or platelet pools). We have excluded
PCs produced but discarded for various reasons other
than outdating (e.g. breaks, and positive serological or
nucleic acid test results), and imported PCs, this repre-
senting very few units.
In contrast to the case of non-perishable items, for
which optimal solutions are known in a variety of set-
tings, the problem of inventory management of perishable
items is much more complicated and optimal solutions
are known only in very specific situations [9, 10]. In
practice, most blood banks use simple heuristic order-up-
to rules for platelet production scheduling [11]. Recently,
there have been some interesting studies based on dis-
crete-event computer simulations, allowing different poli-
cies to be compared [12, 13]. Another interesting
approach is the use of dynamic programming[3–5]; since
the mathematical problem has a high number of dimen-
sions, it cannot be exactly solved in real time and
approximate solutions have been found.
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As we do not include set-up costs or an upper bound
for daily platelet production in our model, we believed
that an order-up-to rule would work well. Note, however,
that the problem is not simple, since demand is not sta-
tionary (rather it depends on the day of the week), pro-
duction is only possible 5 days out of seven, and lead
time is positive and varies (being one day for Monday,
Tuesday, Wednesday and Thursday and three for Friday).
While, in many blood banks, the parameters of the order-
up-to rule are decided empirically [11], we fix them using
a statistical analysis of demand.
Daily PC production
The mathematical model is based on the observed nor-
mality of the distribution of the 2012 data on transfu-
sions carried out on each day of the week, from Monday
to Friday, combining Monday and Tuesday, Tuesday and
Wednesday, Wednesday and Thursday, Thursday to Sun-
day, and Friday to Monday. Specifically, the normality of
data were confirmed in all cases with Shapiro–Wilk and
Kolmogorov–Smirnov tests, using IBM SPSS (ARMONK, NY,
USA) Statistics for Windows, each data set fitting a nor-
mal distribution with corresponding mean and standard
deviation. The same analysis was performed on 2013 data
with similar results in terms of normality and producing
similar statistics to those of 2012.
For each day of the week, we set the order-up-to value
for the production of PC to keep a safety margin, that is
we set it to the mean plus three times the standard devia-
tion of corresponding distribution of 2012 transfusion
data. We selected these values as 997% of the data lie
between l - 3r and l + 3r in normal distribution with
mean l and standard deviation r.
The subscripts i = 1, 2,. . .., 7 indicate the day of the
week from Monday to Sunday and j the week of the
year. The decision regarding how many units of PCs pi,j
to produce on day i of week j is based on the current
stock si,j and the estimate of the units that will be trans-
fused over the days to be covered. The decision depends
on the day of the week, given that the number of units
placed into stock varies through the week. Below, we
briefly outline the model for Monday of week j. The
production of the following day, Tuesday, is not placed
in stock until Wednesday. Hence, regardless of the units
ordered on Tuesday, the demand for Monday and Tues-
day should be covered by p1,j from Monday and stock
s1,j. Keeping a safety margin, the order-up-to value is
set at d1 = l12 + 3r12, where l12 is the mean and r12
The standard deviation of the total number of units
transfused on Mondays and Tuesdays in 2012. Hence,
according to the model, the production p1,j on this Mon-
day is
p1;j ¼ d1  s1;j ð1Þ
or 0 in the event that this quantity is negative. For a
more detailed description of the modelling process, see
Supporting Information.
Simulations performed
Table 1 shows the number of transfusions that should be
covered by each day of production keeping a safety mar-
gin, that is, the order-up-to values. We fixed these values
for all the calculations of the 2013 simulation. The model
allows different parameters to be used for different peri-
ods of the year. Experience indicates that there are fewer
transfusions during the summer, specifically, from the last
week of July to the first week of September. To account
for this, we can adjust the safety margins during the sum-
mer, using the corresponding means for these 6 weeks
from the 2012 data.
To run the simulation, we developed an Excel spread-
sheet that calculates what would have been the daily pro-
duction in 2013 to meet the real demand, using the
model based on 2012 data.
The data used for the calculation are the total units of
PCs in stock broken down by age, the safe demands and
units that expire. More precisely, once the stock si,j,k of
day (i,j) has been updated in the morning, we consider
that a total of pi,j units of PCs are produced according to
eqn (1), equivalent equations for Tuesday or Wednesday,
eqn (2) or eqn (3) (in Appendix S1), depending on the
day of the week, i. The number of units transfused is
taken from the real data for 2013, in line with a FIFO
policy, and outdated units are discarded. The following
morning, the stock is updated by including the most
recently produced PCs and subtracting units that expired
the previous day. This process is repeated day after day,
assuming no production on Saturdays and Sundays.
Table 2 illustrates the steps of this process.
Results
This section shows the results obtained by applying the
Excel spreadsheet to the real transfusion activity in 2013.
Table 3 summarizes the comparison of the main results of
the simulation with real 2013 data. It can be seen that,
using the mathematical model, demand would have been
met with 1442% fewer units of PC and without having
Table 1 Order-up-to values based on keeping a safety margin for each
day of the week
Monday Tuesday Wednesday Thursday Friday
d1 = 81 d2 = 81 d3 = 80 d4 = 124 d5 = 127
© 2016 The Authors.
Vox Sanguinis published by John Wiley & Sons Ltd on behalf of International Society of Blood Transfusion
Vox Sanguinis (2016) 110, 369–375
Optimization of platelet concentrate stocks 371
to import PC. This would have led directly to a very sig-
nificant reduction (9018%) in the quantity of PCs expir-
ing, compared to the real figure. As a secondary effect,
we would have reduced the mean age of PCs transfused
by almost 1 day, there being a 6507% reduction in the
transfusion of 5 day-old PC.
Further, discarding would have been concentrated in a
few days, as can been seen in Fig. 1. Analysing these
peaks in wastage, we found that they arose from excess
production due to having considered Thursday and Friday
in 2 weeks as working days when they were in fact holi-
days, one in Holy Week and the other in December, and
not taking into account the fall in demand for transfu-
sions in the summer. In particular, 36 units expired on
the Tuesday after Holy Week, the largest number of units
expiring on a single day. Given this, we modified the
model, using a value to keep a suitable safety margin
over the aforementioned holidays, namely l1 + 3r1 in
place of l4 + 3r4 and l5 + 3r5, and adjusting the calcu-
lations for the summer as indicated earlier. The result was
the production of 8643 units of PCs (92 fewer) and
67 units expiring (92 fewer), just 078% of those pro-
duced. This demonstrates that in practice stock does need
to be managed differently around such days.
In practical terms, it is very important to ensure a mini-
mum stock at the end of each day. In the model described,
the minimum stock is 3 units. Table 4 shows the results of
the simulations when systematically increasing the pro-
duction on Mondays, Tuesdays and Wednesdays by
k1 units, as defined by the corresponding eqn (1) and that
on Thursdays and Fridays by k2 units, as given by eqns (2)
and (3). It becomes clear that increasing k1 and k2, the
minimum stock increases, while keeping low percentages
of outdating. Figure 2 illustrates the usual behaviour of
the daily PC stock from the mathematical simulation with
k1 = 36 and k2 = 18. Finally, to assess the stability of the
model, we ran the model again using different plausible
data for 2013, and the results obtained were similar.
Discussion
Given rising economic costs, it is of great interest to opti-
mize PC production to ensure efficient use of healthcare
resources. In the literature on blood management, various
papers address this problem using simulation tools [3, 4],
but few have actually been applied to daily practice [3].
On the other hand, there are multiple publications con-
cerning wastage, although the sources are not always
equivalent (hospital-based blood banks, blood transfusion
Table 2 Excel spreadsheet illustrating the 2013 simulation
Daily stock
di pi,j
Number of daily transfusions
Date Day si,j,1 si,j,2 si,j,3 sij,4 si,j,5 si,j xi,j xi,j xi,j,2 xi,j,3 xi,j,4 xi,j,5 eij
12/31/2012 1, 1 0 0 34 41 2 77 81 4 29 0 0 0 27 2 0
01/01/2013 2, 1 4 0 0 34 14 52 81 29 10 0 0 0 0 10 4
01/02/2013 3, 1 29 4 0 0 34 67 80 13 31 0 0 0 0 31 3
01/03/2013 4, 1 13 29 4 0 0 46 124 78 16 0 12 4 0 0 0
01/04/2013 5, 1 78 13 17 0 0 108 127 19 27 0 10 17 0 0 0
01/05/2013 6, 1 0 78 3 0 0 81 0 0 13 0 10 3 0 0 0
01/06/2013 7, 1 0 0 68 0 0 68 0 0 9 0 0 9 0 0 0
01/07/2013 1, 2 0 0 19 59 0 78 81 3 34 0 0 0 34 0 0
01/08/2013 2, 2 3 0 0 19 25 47 81 34 23 0 0 0 0 23 2
01/09/2013 3, 2 34 3 0 0 19 56 80 24 24 2 3 0 0 19 0
01/10/2013 4, 2 24 32 0 0 0 56 124 68 31 0 31 0 0 0 0
01/11/2013 5, 2 68 24 1 0 0 93 127 34 26 1 24 1 0 0 0
01/12/2013 6, 2 0 67 0 0 0 67 0 0 16 0 16 0 0 0 0
01/13/2013 7, 2 0 0 51 0 0 51 0 0 14 0 0 14 0 0 0
01/14/2013 1, 3 0 0 34 37 0 71 81 10 35 0 0 0 35 0 0
With subscripts i = 1, 2,. . .., 7 indicating the day of the week from Monday to Sunday and j the week of the year, xi,j are real units transfused in 2013,
pi,j and ei,j are units needed to be ordered and discarded each day due to expiry as calculated by the model, and si,j,k and xi,j,k with k = 1, 2,. . .., 7 are
the stock and transfusions of units k days old, respectively. Platelet concentrate was supplied according to a first-in, first-out policy.
Table 3 Results of the simulation and real data from 2013
Estimate Real data
Units of platelet concentrate produced 8735 10 207
Units of platelet concentrate expiring 159 1619
% Units expiring 182 1586
Shortfall in units of platelet concentrate 0 0
Average age of units transfused (days) 296 389
Units transfused at 5 days old 1142 3269
% Units transfused at 5 days old 1330% 3806%
© 2016 The Authors.
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centres) and there are differences in the definition of a PC
dose, which makes benchmarking difficult. The Blood
Stock Management Scheme in the United Kingdom and
Republic of Ireland represents a similar situation to ours,
being based on pooled data sets from blood services and
hospitals. In 2010, in UK and North UK, where 7 day
storage is permitted, wastage as a percentage of issues
was 72%, while in UK and the Republic of Ireland, where
storage is limited to 5 days, these rates were 141 and
142%, respectively [14].
In our opinion, the wastage of blood components and
in particular PCs should be addressed together across the
whole transfusion chain, not independently in production
units and hospitals. For this, it is essential to have a good
IT system that provides data on the production and trans-
fusion of PCs across all the area covered. In the Basque
Country, the operation of the transfusion system as a
co-ordinated network is established by law and there is a
single corporate information system, shared between the
CVTTH and the great majority of transfusion centres. The
wastage rate in the Basque Country is 1586%, 142% of
units being discarded in hospital transfusion centres. The
low wastage of PCs in the CVTTH is attributable to the
fact that units supplied, to hospitals that keep PCs in
stock or for transfusions in health centres that do not
hold stock, are always the oldest available (following the
FIFO policy). The mean age of PCs supplied by the CVTTH
is 35 days.
The mathematical model proposed should be consid-
ered an approximation to the real situation, given its var-
ious limitations. These include the following: (i)
neglecting the influence of outdating, this being relatively
small; (ii) considering a single PC stock in the Basque
Country, rather than including separately the main stock
in the CVTTH and secondary stocks held in five hospitals,
meaning that it does not take into account problems
associated with distribution and cumulative ageing of PCs
held in storage consecutively at two sites; (iii) assuming
that the oldest PCs are always used first (FIFO policy); (iv)
ignoring ABO/Rh group and other variables associated
with PC processing (washing, radiation, preparation of
aliquots for paediatric patients, etc.), while in routine
practice clinicians always seek to achieve ABO-compat-
ibility; (v) fixing the number of days of production at
five, that is, excluding Saturdays; (vi) not taking into
Fig. 1 Number of units of platelet concentrate
expiring per day in the simulation of 2013.
Fig. 2 Daily stock of platelet concentrate
during 2013 given by the model taking k1 = 36
and k2 = 18.
Table 4 Results obtained from the model when systematically increasing
the production on Mondays, Tuesdays and Wednesdays by k1 units and











0 0 3 182 296
4 2 7 226 306
12 6 13 316 324
20 10 17 415 342
28 14 21 533 358
36 18 25 656 373
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account potential limitations in the daily production due to
marked decreases in donations; (vii) excluding units pro-
duced that are not placed in stock, due to abnormal test
results, bag ruptures, etc. (n = 40); (viii) disregarding
apheresis platelets imported for refractory patients (n = 3);
and (ix) not considering independently bank holidays and
special occasions, such as Easter. On the other hand, we
consider that the differences between the PC products
(pooled and single-donor apheresis platelets) used in the
Basque Country are not relevant to this analysis.
This work gives the CVTTH a new way of managing PC
production, making the decision-making more rational
and less empirical. The cornerstone of the approach is the
demonstration that transfusions performed on each day
of the week follow a normal distribution over time. Con-
sequently, it can be assumed with a high level of cer-
tainty that to avoid a shortage of PC, we should produce
up to the level of the mean usage plus three times the
standard deviation for the corresponding days in the pre-
vious year. The tool designed calculates the quantity of
PCs that the CVTHH should produce as a function of the
available stock, without triggering excessive production.
Its use makes it possible to reduce PC production by as
much as 1442% (1472 fewer units), without causing
stock shortages.
All this undoubtedly has significant economic conse-
quences. Considering the prices established for 2013 in
the Basque Country, the potential savings associated with
the proposed decrease in PC production would range from
€42080478 to €69270402, depending on whether the
PCs were obtained by pooling or apheresis, considering
unit costs of €28842 and €47478, respectively. What is
more, the mean age of PCs transfused would be reduced
by almost 1 day, with the corresponding clinical benefits
for patients [15].
Additionally, this study supports the FIFO policy for
the use of PC, with exceptions and limitations as neces-
sary in real practice. Our findings have encouraged the
introduction of collaborative and logistic measures to
facilitate transfers of PC, in particular, 4 and 5 day-old
units, between the CVTTH and transfusion centres as
described in previous studies [11].
To conclude, this study is useful to improve our under-
standing of the dynamics of production, distribution and
transfusion of PCs in the Basque Country and makes it
possible to establish some new guidelines. However, we
consider that this model can only be used as a support
tool in decision-making concerning platelet production,
given its notable limitations We must now evaluate the
aforementioned changes in procedures to assess the effec-
tiveness of the measures adopted under real-world condi-
tions, with the expectation that the results obtained will
not be as optimal as those in the simulations. We should
also note that, comparing 2012 and 2013 data, we
observed a variation in the means and standard devia-
tions of the quantities of PCs transfused each day of the
week, underlining the need to regularly update the
parameters of the model; in particular, this will ensure
that the progressive increase in the demand for PCs is
taken into account [16]. As a prerequisite for all this
analysis, it is essential to have working methods and
information systems that provide reliable and accurate
information across the entire transfusion network in real
time.
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